Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Plus Therapeutics Q2 Sales $1.28M Miss $1.68M Estimate

Author: Benzinga Newsdesk | August 14, 2024 04:15pm
Plus Therapeutics (NASDAQ:PSTV) reported quarterly sales of $1.28 million which missed the analyst consensus estimate of $1.68 million by 23.64 percent. This is a 31.01 percent decrease over sales of $1.85 million the same period last year.

Posted In: PSTV


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist